引用本文:徐 红,李 琤,金水忠.乳果糖治疗乙型肝炎后肝硬化内毒素血症的疗效观察[J].中国临床新医学,2011,4(5):451-453.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1318次   下载 931 本文二维码信息
码上扫一扫!
分享到: 微信 更多
乳果糖治疗乙型肝炎后肝硬化内毒素血症的疗效观察
徐 红,李 琤,金水忠
201400 上海,上海市奉贤区古华医院肝病科
摘要:
[摘要] 目的 观察乳果糖治疗乙型肝炎后肝硬化内毒素血症的临床疗效。方法 将70例乙型肝炎后肝硬化伴血清内毒素血症的患者随机分为两组,对照组35例予以常规保肝降酶退黄治疗,治疗组35例在常规保肝降酶退黄治疗的基础上加用乳果糖口服20 d,分别观察两组患者在治疗前后血清内毒素水平的变化。结果 乳果糖治疗组内毒素血症的复常率为85.7%,明显高于对照组45.6%(χ2=10.94,P<0.01)。治疗组血清内毒素水平、丙氨酸氨基转氨酶(ALT)、天冬氨酸氨基转氨酶(AST)、总胆红素(TBIL)有显著下降,血清白蛋白(A)升高,显著优于对照组(P<0.05或P<0.01)。结论 乳果糖具有显著降低乙型肝炎后肝硬化血清内毒素水平的作用,乳果糖可防治乙型肝炎后肝硬化内毒素血症。
关键词:  乙型肝炎  肝硬化  内毒素  乳果糖
DOI:10.3969/j.issn.1674-3806.2011.05.19
分类号:R 512.6
基金项目:
Effect of lactulose in treating endotoxemia in patients with hepatic cirrhosis due to hepatitis B
XU Hong, LI Cheng, JIN Shui-zhong
Guhua Hospital,Fengxian District,Shanghai 201400,China
Abstract:
[Abstract] Objective To observe the clinical efficacy of lactulose in treaing endotoxemia in patients with hepatic cirrhosis due to hepatitis B.Methods Seventy patients with hepatic cirrhosis due to hepatitis B were randomly divided into the treated group(n=35) and the control group(n=35). Patients in the control group received conventional treatments for 20 days. Besides conventional treatments, patients in the treated group received lactulose for 20 days.Results In the treated group, the improvement rate of endotoxemia was 85.7%,significantly better than the control group 45.6% (χ2=10.94, P<0.01). Serum endotoxin, ALT、AST and TBIL were all lower in the treated group than those in the control group (P<0.05 or P<0.01).Conclusion Lacunose can decrease the level of serum endotoxin. Lactulose is significant effective in the treatment of endotoxemia in patients with hepatic cirrhosis due to hepatitis B, and better than the control group.
Key words:  Hepatic cirrhosis  Hepatitis B  Endotoxin  Lactulose